Yiling

Yiling (以岭) is a proprietary Chinese medicine brand of Shijiazhuang Yiling Pharmaceutical Co., Ltd. Its cardiovascular medicines include Qili Qiangxin Capsule (芪苈强心胶囊), developed for chronic heart failure, and Shensong Yangxin Capsule (参松养心胶囊), used for cardiac rhythm disorders. Other products address respiratory health, metabolic conditions, and additional therapeutic areas.

Founded in Shijiazhuang in 1992, Shijiazhuang Yiling Pharmaceutical researches, develops, manufactures, and sells medicines. The publicly listed company operates in proprietary Chinese medicine as well as chemical and biological medicines. It has research and production bases in Hebei and Beijing and maintains a broad manufacturing and quality-control system.

Yiling’s work connects traditional Chinese medicine research with contemporary pharmaceutical development. Its Chinese medicine range includes products for cardiovascular conditions, respiratory infections, diabetes, and other areas. The company’s portfolio includes both established formulations and newer medicines developed through its research programs. It also supports research on Chinese medicine theory through academic and clinical programs, applying that work to new proprietary medicines.